Deep Anterior Lamellar Keratoplasty (DALK)

Since DALK preserves your own endothelium, the part of the eye most likely to trigger an immune response, your body is much less likely to reject the donor tissue. Studies show that rejection rates are approximately 9 percent for DALK compared to 21 percent for full-thickness transplants. This lower rejection risk means better long-term graft survival and fewer complications.

Patients generally experience quicker healing with DALK because the surgery preserves more of the cornea's natural structure and does not enter the inside of the eye. Many people can return to light daily activities within one to two weeks, with vision steadily improving over the following months. Complete visual rehabilitation typically takes three to six months, which is faster than traditional transplants.

By keeping the innermost corneal layer intact, DALK helps maintain the structural integrity of your eye and lowers the risk of serious complications. Research shows that approximately 70 to 75 percent of patients achieve functional vision good enough for daily activities, including driving, with glasses or contact lenses after DALK. The preserved endothelium also provides better stability for future procedures if ever needed.

Because the risk of rejection is significantly lower with DALK, many patients require fewer anti-rejection medications over time. This means less exposure to corticosteroid eye drops, which can cause side effects such as cataracts, elevated eye pressure, and increased infection risk. A lower medication burden improves quality of life and reduces long-term healthcare costs.

The surgery itself is not painful because local anesthesia numbs your eye completely. Afterward, most people experience only mild discomfort, such as a scratchy or gritty feeling, for a few days. This is easily managed with prescribed pain relievers and lubricating eye drops. Severe pain is unusual and should be reported to your doctor immediately.

You may notice some improvement in your vision within the first few weeks, but full healing and visual stabilization typically take six to 18 months. During this time, your prescription will change as the cornea heals and the sutures are adjusted or removed. Most patients need glasses or contact lenses to achieve their best vision, and your prescription will be fine-tuned as your eye stabilizes.

DALK has an excellent success rate, with studies showing 95 to 97 percent long-term graft survival at 10 years in carefully selected patients, particularly those with keratoconus. Most patients experience significant vision improvement and a much lower risk of rejection compared to traditional full-thickness transplants. Outcomes depend on the underlying condition, surgical technique, and adherence to post-operative care.

DALK is best for patients whose corneal disease affects only the outer or middle layers while the endothelium remains healthy. Common candidates include those with keratoconus, corneal scars, or anterior corneal dystrophies. If the endothelium is damaged or diseased, a full-thickness transplant or an endothelial keratoplasty procedure is usually more appropriate. Your surgeon will use specialized imaging to determine which procedure is right for you.

Some astigmatism, or irregular corneal shape, is common after any corneal transplant. Your surgeon can manage this by selectively removing or adjusting sutures over time to reshape the cornea and reduce astigmatism. Once your cornea stabilizes, any remaining astigmatism can be corrected with prescription eyeglasses, specialty contact lenses such as rigid gas-permeable lenses, or in some cases, laser vision correction.

The sutures used in DALK are very fine and are usually left in place for several months to a year or longer. Your surgeon will use advanced corneal imaging, called topography, to create detailed maps of your cornea and guide the gradual removal process. Removing sutures strategically helps reduce astigmatism and fine-tune your vision. Suture removal is typically done in the office and is quick and painless.

Although the risk of rejection is much lower with DALK than with full-thickness transplants, it can still occur. Warning signs include redness, increased light sensitivity, blurred or decreased vision, and eye pain or discomfort. Any of these symptoms should prompt an urgent call to your eye care team. If caught early, rejection can often be reversed with intensive steroid eye drops.

Most patients can return to light activities, such as desk work and reading, within one to two weeks after surgery. You should avoid rubbing your eye, heavy lifting, swimming, hot tubs, contact sports, and activities that could expose your eye to dust or debris for at least four to six weeks or until cleared by your surgeon. Returning to work and other activities depends on your job and how quickly your eye heals.